ProCE Banner Activity

HIV and the Liver at CROI 2023

Conference Coverage
Clinical Thought

Read my take on studies of HIV/HBV coinfection—including selection of HBV-based ART and hepatocellular carcinoma screening—and considerations for assessing nonalcoholic fatty liver disease in people with HIV.

Released: March 14, 2023

Expiration: March 12, 2024

Share

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Disclosure

Prof Gail Matthews, MD, PhD: consultant: AstraZeneca, Janssen; researcher: AbbVie, Gilead Sciences, ViiV Healthcare.